Volume 11, Number 3—March 2005
Dispatch
Concomitant Tickborne Encephalitis and Human Granulocytic Ehrlichiosis
Stanka Lotric-Furlan*
, Miroslav Petrovec†, Tatjana Avsic-Zupanc†, and Franc Strle*
, Miroslav Petrovec†, Tatjana Avsic-Zupanc†, and Franc Strle*
Table 2
Results of PCR analysis and serum antibody titers to different tickborne pathogens tested at different times after the onset of illness*
| Days after onset of illness | PCR† 16S RNA gene | ELISA IgM/IgG‡ TBEV | IFA IgG A. phagocytophilum | IFA IgM/IgG E. chaffeensis | |
|---|---|---|---|---|---|
| Anaplasma phagocytophilum | Ehrlichia chaffeensis | ||||
| 12 | Pos | Neg | 0.614/129 | Neg | Neg/neg |
| 14 | Neg | Neg | 1.369/251 | 512 | Neg/neg |
| 20 | – | – | 1.187/382 | 2,048 | Neg/neg |
| 45 | – | – | 0.419/220 | 512 | Neg/neg |
| 144 | – | – | 0.400/179 | 512 | Neg/neg |
*PCR, polymerase chain reaction; ELISA, enzyme-linked immunosorbent assay; IFA, indirect immunofluorescence assay; Ig, immunoglobulin; Neg, negative; Pos, positive; TBEV, tickborne encephalitis virus. †Primers Ehr521 and Ehr790 specific to A. phagocytophilum and primers HE1 and HE3 specific to E. chaffeensis. ‡Cut-off value for TBEV IgM is 0.272–0.372 and for IgG is 7.5 U/mL, according to the manufacturer's procedure
Page created: April 25, 2012
Page updated: April 25, 2012
Page reviewed: April 25, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.